Peter Moran

Fundador en Singular ID Pte Ltd. .

Technology Services

Consumer Services

Health Technology

Perfil

Peter Moran is Chief Technology Officer and a Director Singular ID Pte Ltd.
Previously, he was a Senior Scientist of IMRE.
Dr. Morean received a PhD in Engineering and an MS degree in Applied Mathematics and Engineering from Brown University.

Cargos activos de Peter Moran

Empresas	Cargo	Inicio
Singular ID Pte Ltd. Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore.	Fundador	-

Todos los cargos activos de Peter Moran

Antiguos cargos conocidos de Peter Moran.

Empresas	Cargo	Fin
Cypress Bioscience, Inc. Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Peter Moran.

Formación de Peter Moran.

Brown University

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Peter Moran.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Singular ID Pte Ltd. Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore.	Technology Services
Cypress Bioscience, Inc. Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA.	Health Technology